Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,143.00
+1.00 (0.09%)
Jun 3, 2026, 3:15 PM JST
Takara Bio Market Cap
Takara Bio has a market cap or net worth of 137.51 billion as of June 2, 2026. Its market cap has increased by 39.95% in one year.
Market Cap
137.51B
Enterprise Value
128.35B
Revenue
40.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,143.00
Market Cap Chart
Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 137.51B, an increase of 152.34%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 137.51B | 43.65% |
| Dec 30, 2025 | 95.73B | -24.29% |
| Dec 30, 2024 | 126.44B | -16.13% |
| Dec 29, 2023 | 150.76B | -27.34% |
| Dec 30, 2022 | 207.48B | -34.83% |
| Dec 30, 2021 | 318.38B | -4.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 143.04B |
| GNI Group | 141.95B |
| SanBio Company | 111.44B |
| Nxera Pharma | 97.88B |
| Oncolys BioPharma | 80.97B |
| Healios K.K. | 45.23B |
| Cuorips | 40.92B |
| Japan Tissue Engineering | 25.02B |